申请人:DAIICHI SEIYAKU CO., LTD.
公开号:EP0159707A2
公开(公告)日:1985-10-30
Novel triazolopyrimidine compounds represented by the formula (I) and physiologically acceptable salts thereof are disclosed. These compounds have an excellent antial- lergic activity in oral administration and are useful for treatment and prophylaxis of allergic diseases such as bronchial asthma, allergic gastro-intestinal disorders, allergic rhinitis, hay fever, urticaria and the like.
本发明公开了由式(I)表示的新型三唑并嘧啶化合物及其生理上可接受的盐类。这些化合物口服具有极佳的抗过敏活性,可用于治疗和预防过敏性疾病,如支气管哮喘、过敏性胃肠道疾病、过敏性鼻炎、花粉症、荨麻疹等。